UBS Group »

BioCryst Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $45M 6.0M 7.59
2025-06-30 $50M 5.6M 8.96
2025-03-31 $18M 2.4M 7.50
2024-12-31 $1.9M 248k 7.52
2024-09-30 $3.3M 433k 7.60
2024-06-30 $2.5M 400k 6.18
2024-03-31 $5.1M 997k 5.08
2023-12-31 $4.1M 685k 5.99
2023-09-30 $2.2M 306k 7.08
2023-06-30 $3.1M 442k 7.04
2023-03-31 $3.6M 433k 8.34
2022-12-31 $7.4M 646k 11.48
2022-09-30 $2.6M 206k 12.64
2022-06-30 $1.6M 152k 10.30
2022-03-31 $2.3M 143k 16.25
2021-12-31 $7.4M 533k 13.85
2021-09-30 $4.9M 338k 14.37
2021-06-30 $2.9M 179k 16.18
2021-03-31 $1.9M 189k 10.17
2020-12-31 $3.9M 528k 7.46
2020-09-30 $4.9M 1.4M 3.43
2020-06-30 $757k 159k 4.77
2020-03-31 $10M 5.1M 2.00
2019-12-31 $19M 5.5M 3.45
2019-09-30 $8.7M 3.0M 2.86
2019-06-30 $8.4M 2.2M 3.80
2019-03-31 $4.2M 511k 8.13
2018-12-31 $1.0M 126k 8.07
2018-09-30 $854k 112k 7.63
2018-06-30 $362k 63k 5.72
2018-03-31 $1.4M 291k 4.78
2017-12-31 $493k 100k 4.92
2017-09-30 $599k 114k 5.25
2017-06-30 $353k 64k 5.56
2017-03-31 $605k 72k 8.40
2016-12-31 $632k 100k 6.33
2016-09-30 $388k 88k 4.40
2016-06-30 $241k 84k 2.86
2016-03-31 $208k 73k 2.86
2015-12-31 $1.5M 146k 10.32
2015-09-30 $873k 77k 11.40
2015-03-31 $688k 74k 9.29